Cancer, cognitive impairment, and meditation

References

• Wefel JS, Kayl AE, Meyers CA. Neuropsychological dysfunction associated with cancer and cancer therapies: A conceptual review of an emerging target. Br J Cancer 2004; 90: 1691–6
   PubMed Web of Science ®Google Scholar
• Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007; 7: 192–201
   PubMed Web of Science ®Google Scholar
• Bower JE. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 2008; 26: 768–77
   PubMed Web of Science ®Google Scholar
• Tannock IF, Ahles TA, Ganz PA, Van Dam FS. Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. J Clin Oncol 2004; 22: 2233–9
   PubMed Web of Science ®Google Scholar
• Vardy J, Tannock I. Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol 2007; 63: 183–202
   PubMed Web of Science ®Google Scholar
• NCI. President's Cancer Panel Meeting. Cancer care issues in the United States quality of care, quality of life, January 1, 1997 to December 31, 1998: National Cancer Institute.
   Google Scholar
• NCCS. Palliative care and symptom management. Cognitive Issues [ cited; Available from: http://www.canceradvocacy.org/resources/essential/effects/cognitive_test.aspx ( accessed February 2007)
   Google Scholar
• Kohli S, Fisher SG, Tra Y, Wesnes K, Morrow GR. The cognitive effects of modafinil in breast cancer survivors: A randomized clinical trial. ASCO Annual Meeting; 2007.
   Google Scholar
• Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions. Palliat Support Care 2007; 5: 273–80
   PubMedGoogle Scholar
• O'Shaughnessy JA, Vukelja SJ, Holmes FA, Savin M, Jones M, Royall D, et al. Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Clin Breast Cancer 2005; 5: 439–46
   PubMedGoogle Scholar
• Rozans M, Dreisbach A, Lertora JJ, Kahn MJ. Palliative uses of methylphenidate in patients with cancer: A review. J Clin Oncol 2002; 20: 335–9
   PubMedGoogle Scholar
• Gordon L, Graves N, Hawkes A, Eakin E. A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol. Chronic Illn 2007; 3: 101–29
   PubMedGoogle Scholar
• Stant AD, Ten Vergert EM, den Boer PC, Wiersma D. Cost-effectiveness of cognitive self-therapy in patients with depression and anxiety disorders. Acta Psychiatr Scand 2008; 117: 57–66
   PubMedGoogle Scholar
• Bandura A. Health promotion by social cognitive means. Health Educ Behav 2004; 31: 143–64
   PubMed Web of Science ®Google Scholar
• Basen-Engquist K, Taylor CL, Rosenblum C, Smith MA, Shinn EH, Greisinger A, et al. Randomized pilot test of a lifestyle physical activity intervention for breast cancer survivors. Patient Educ Couns 2006; 64: 225–34
   PubMed Web of Science ®Google Scholar
• Demark-Wahnefried W, Clipp EC, Lipkus IM, Lobach D, Snyder DC, Sloane R, et al. Main outcomes of the FRESH START trial: A sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol 2007; 25: 2709–18
   PubMed Web of Science ®Google Scholar
• Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, et al. Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology. 2007; 16: 772–7
   PubMed Web of Science ®Google Scholar
• Brady MJ, Peterman AH, Fitchett G, Mo M, Cella D. A case for including spirituality in quality of life measurement in oncology. Psychooncology 1999; 8: 417–28
   PubMed Web of Science ®Google Scholar
• Carmody J, Reed G, Kristeller J, Merriam P. Mindfulness, spirituality, and health-related symptoms. J Psychosom Res 2008; 64: 393–403
   PubMed Web of Science ®Google Scholar
• Mackenzie MJ, Carlson LE, Speca M. Mindfulness-Based Stress Reduction (MBSR) in oncology: Rationale and review. Evidence-Based Integrat Med 2005; 2: 139–45
   Google Scholar
• Matchim Y, Armer JM. Measuring the psychological impact of mindfulness meditation on health among patients with cancer: A literature review. Oncol Nurs Forum 2007; 34: 1059–66
   PubMed Web of Science ®Google Scholar
• Winbush NY, Gross CR, Kreitzer MJ. The effects of mindfulness-based stress reduction on sleep disturbance: A systematic review. Explore (NY) 2007; 3: 585–91
   PubMedGoogle Scholar
• Brefczynski-Lewis J, Lutz A, Schaefer H, Levinson D, Davidson R. Neural correlates of attentional expertise in long-term meditation practioners. Proc Natl Acad Sci USA 2007; 104: 11483–8
   PubMed Web of Science ®Google Scholar
• Jha A, Krompinger J, Baime M. Mindfulness training modifies subsystems of attention. Cogn Affect Behav Neurosci 2007; 7: 109–19
   PubMed Web of Science ®Google Scholar
• Slagter H, Lutz A, Greischar LL, Francis A, Nieuwenhuis S, Davis J, et al. Mental training affects distribution of limited brain resources. Public Libr Sci Biol 2007; 5: 1228–35
   Google Scholar
• Harrison L, Manocha R, Rubia K. Sahaja Yoga meditation as a family treatment programme for children with attention deficit-hyperactivity disorder. Clin Child Psychol Psychiatry 2004; 9: 479–97
   Google Scholar
• Stevenson CS, Whitmont S, Bornholt L, Livesey D, Stevenson RJ. A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder. Aust N Z J Psychiatry. 2002; 36: 610–6
   PubMed Web of Science ®Google Scholar
• Zylowska L, Ackerman DL, Yang MH, Futrell JL, Horton NI, Hale S, et al. Mindfulness meditation training in adults and adolescents with ADHD: A feasibility study. J Atten Disord 2007.
   PubMedGoogle Scholar
• Doraiswamy PM, Xiong GL. Does meditation enhance cognition and brain longevity? Ann N Y Acad Sci 2007.
   Google Scholar
• Khalsa D, Newberg A. Stress, meditation, SPECT scans, and dementia prevention. Alzheimer Demen 2007; 3: S126
   PubMedGoogle Scholar
• Pagnoni G, Cekic M. Age effects on gray matter volume and attentional performance in Zen meditation. Neurobiol Aging 2007; 28: 1623–7
   PubMed Web of Science ®Google Scholar
• Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002; 20: 485–93
   PubMed Web of Science ®Google Scholar
• Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 2004; 26: 955–69
   PubMed Web of Science ®Google Scholar
• Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999; 85: 640–50
   PubMed Web of Science ®Google Scholar
• van Dam FS, Schagen SB, Muller MJ, Boogerd W, Wall E, Droogleever Fortuyn ME, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998; 90: 210–8
   PubMed Web of Science ®Google Scholar
• Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M. What do cancer patients mean when they complain of concentration and memory problems?. Br J Cancer 1996; 74: 1674–9
   PubMed Web of Science ®Google Scholar
• Downie FP, Mar Fan HG, Houede-Tchen N, Yi Q, Tannock IF. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: Evaluation with patient interview after formal assessment. Psychooncology. 2006; 15: 921–30
   PubMed Web of Science ®Google Scholar
• Ahles TA, Saykin AJ. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 2002; 3(Suppl 3)S84–S90
   PubMedGoogle Scholar
• Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000; 18: 2695–701
   PubMed Web of Science ®Google Scholar
• Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Ann Oncol 2008; 19: 623–9
   PubMed Web of Science ®Google Scholar
• Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 1995; 4: 61–6
   Web of Science ®Google Scholar
• Ferguson RJ, Ahles TA. Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. Curr Neurol Neurosci Rep 2003; 3: 215–22
   PubMedGoogle Scholar
• Saykin AJ, Ahles TA, McDonald BC. Mechanisms of chemotherapy-induced cognitive disorders: Neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry 2003; 8: 201–16
   PubMedGoogle Scholar
• Schagen SB, Hamburger HL, Muller MJ, Boogerd W, van Dam FS. Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neurooncol 2001; 51: 159–65
   PubMed Web of Science ®Google Scholar
• Kreukels BP, Schagen SB, Ridderinkhof KR, Boogerd W, Hamburger HL, van Dam FS. Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Res Treat 2005; 94: 53–61
   PubMed Web of Science ®Google Scholar
• Inagaki M, Yoshikawa E, Matsuoka Y, Sugawara Y, Nakano T, Akechi T, et al. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 2007; 109: 146–56
   PubMed Web of Science ®Google Scholar
• Silverman DH, Castellon SA, Abraham L, Dy CJ, Pio BS, Ganz PA, et al. Abnormal brain metabolism in breast cancer survivors after adjuvant chemotherapy is associated with cognitive changes. Proc Am Soc Clin Oncol 2003.
   Google Scholar
• Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat 2006.
   Google Scholar
• Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer 2004; 100: 2292–9
   PubMed Web of Science ®Google Scholar
• Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 2007 May 1; 109(1)1905–13
   PubMedGoogle Scholar
• Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. ‘Chemobrain’ in breast carcinoma?: A prologue. Cancer 2004; 101: 466–75
   PubMed Web of Science ®Google Scholar
• Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology 2004; 13: 61–6
   PubMed Web of Science ®Google Scholar
• Castellon SA, Ganz PA, Abraham L, Bower JE, Pakilit A, Petersen L, et al Neurocognitive performance in breast cancer following exposure to adjuvant systemic therapy. National Academy of Neuropsychology 2001; San Francisco 2001;p. 859–60.
   Google Scholar
• Alibhai SM, Gogov S, Allibhai Z. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: A systematic literature review. Crit Rev Oncol Hematol 2006; 60: 201–15
   PubMed Web of Science ®Google Scholar
• Beauchet O. Testosterone and cognitive function: Current clinical evidence of a relationship. Eur J Endocrinol 2006; 155: 773–81
   PubMed Web of Science ®Google Scholar
• Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002; 64: 604–11
   PubMed Web of Science ®Google Scholar
• Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 2005; 104: 788–93
   PubMed Web of Science ®Google Scholar
• Capuron L, Ravaud A, Dantzer R. Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom Med 2001; 63: 376–86
   PubMed Web of Science ®Google Scholar
• Ganz PA, Bower JE. Cancer-related fatigue: A focus on breast cancer and Hodgkin's disease survivors. Acta Oncol 2007; 46: 474–9
   PubMed Web of Science ®Google Scholar
• Staat K, Segatore M. The phenomenon of chemo brain. Clin J Oncol Nurs 2005; 9: 713–21
   PubMedGoogle Scholar
• Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998; 16: 2522–7
   PubMed Web of Science ®Google Scholar
• Challman TD, Lipsky JJ. Methylphenidate: Its pharmacology and uses. Mayo Clin Proc 2000; 75: 711–21
   PubMed Web of Science ®Google Scholar
• Butler JM, Jr, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys 2007; 69: 1496–501
   PubMed Web of Science ®Google Scholar
• Mar Fan HG , Clemons M , Xu W , Chemerynsky I , Breunis H , Braganza S , et al . A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 2007.
   PubMedGoogle Scholar
• Pigeau R, Naitoh P, Buguet A, McCann C, Baranski J, Taylor M, et al. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 1995; 4: 212–28
   PubMed Web of Science ®Google Scholar
• Kaleita TA, Wellisch DK, Graham CA, Nghiemphu S, Ford JM, Lai A, et al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. Am Soc Clin Oncol. J Clin Oncol 2006; 2006: 58
   Google Scholar
• Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K. Management of cancer-related fatigue. Cancer Invest 2005; 23: 229–39
   PubMed Web of Science ®Google Scholar
• Gordon J, Curtin S. Comprehensive cancer care: Integrating alternative, complementary, and conventional therapies. Perseus Publishing, Cambridge, Massachusetts 2000
   Google Scholar
• Wallace RK, Benson H, Wilson AF. A wakeful hypometabolic physiologic state. Am J Physiol 1971; 221: 795–9
   PubMed Web of Science ®Google Scholar
• Dietrich A. Functional neuroanatomy of altered states of consciousness: The transient hypofrontality hypothesis. Conscious Cogn 2003; 12: 231–56
   PubMed Web of Science ®Google Scholar
• Newberg AB, Iversen J. The neural basis of the complex mental task of meditation: neurotransmitter and neurochemical considerations. Med Hypotheses 2003; 61: 282–91
   PubMed Web of Science ®Google Scholar
• Lutz A, Slagter HA, Dunne JD, Davidson RJ. Attention regulation and monitoring in meditation. Trends Cogn Sci 2008; 12: 163–9
   PubMed Web of Science ®Google Scholar
• So K, Orme-Johnson D. Three randomized experiments on the longitudinal effects of the transcendental meditation technique on cognition. Intelligence 2001; 29: 419–40
   Web of Science ®Google Scholar
• Valentine ER, Sweet PLG. Meditation and attention: A comparison of the effects of concentrative and mindfulness meditation on sustained attention. Ment Health Rel Cult 1999; 2: 59–70
   Google Scholar
• Lazar SW, Kerr CE, Wasserman RH, Gray JR, Greve DN, Treadway MT, et al. Meditation experience is associated with increased cortical thickness. Neuroreport 2005; 16: 1893–7
   PubMed Web of Science ®Google Scholar
• van Veen V, Cohen JD, Botvinick MM, Stenger VA, Carter CS. Anterior cingulate cortex, conflict monitoring, and levels of processing. Neuroimage 2001; 14: 1302–8
   PubMed Web of Science ®Google Scholar
• Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF, et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med 2003; 65: 564–70
   PubMed Web of Science ®Google Scholar
• Lutz A, Greischar LL, Rawlings NB, Ricard M, Davidson RJ. Long-term meditators self-induce high-amplitude gamma synchrony during mental practice. Proc Natl Acad Sci U S A 2004; 101: 16369–73
   PubMed Web of Science ®Google Scholar
• Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med 2005; 12: 278–85
   PubMed Web of Science ®Google Scholar
• Carlson LE, Speca M, Faris P, Patel KD. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun 2007; 21: 1038–49
   PubMed Web of Science ®Google Scholar
• Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: Theoretical considerations and preliminary results. Gen Hosp Psychiatry 1982; 4: 33–47
   PubMed Web of Science ®Google Scholar
• Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 2000; 62: 613–22
   PubMed Web of Science ®Google Scholar
• Davidson RJ. Affective style, psychopathology, and resilience: Brain mechanisms and plasticity. Am Psychol 2000; 55: 1196–214
   PubMed Web of Science ®Google Scholar
• Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 2003; 65: 571–81
   PubMed Web of Science ®Google Scholar
• Ospina MB, Bond K, Karkhaneh M, Tjosvold L, Vandermeer B, Liang Y, et al. Meditation practices for health: State of the research. Evid Rep Technol Assess (Full Rep) 2007; 155: 1–263
   Google Scholar